{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T17:13:41Z","timestamp":1789146821263,"version":"build-2803163510"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>High-quality hypertension management is a new concept proposed to improve blood pressure (BP) control in Asia. Out-of-office BP measurements, including ambulatory and home BP monitoring, and wearable BP measurement, are recommended for BP assessment. Long-acting antihypertensive agents at full dose or in combination are priority strategies for achieving 24-h (24-h) BP control, reducing blood pressure variability (BPV) and improving time-in-target range (TTR). High-quality hypertension management across multiple disciplines will be a pragmatic strategy for the reduction in the risk of cardio-cerebrovascular and renal complications and mortality among Asian hypertensive patients.<\/jats:p>","DOI":"10.1038\/s41440-026-02644-2","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T04:17:55Z","timestamp":1778559475000},"page":"2141-2155","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Asian expert consensus on high-quality hypertension management"],"prefix":"10.1038","volume":"49","author":[{"given":"Jing","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuomi","family":"Kario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqiang","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianli","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yook-Chin","family":"Chia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhua","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Hoshide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijuan","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinho","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apichard","family":"Sukonthasarn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boon Wee","family":"Teo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuda","family":"Turana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Guang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,12]]},"reference":[{"key":"2644_CR1","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/s41440-024-01622-w","volume":"47","author":"K Kario","year":"2024","unstructured":"Kario K, Okura A, Hoshide S, Mogi M. The WHO Global report 2023 on hypertension warning the emerging hypertension burden in globe and its treatment strategy. Hypertens Res. 2024;47:1099\u2013102.","journal-title":"Hypertens Res"},{"key":"2644_CR2","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0140-6736(21)01330-1","volume":"398","author":"NCD Risk Factor Collaboration (NCD-RisC)","year":"2021","unstructured":"NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021;398:957\u201380.","journal-title":"Lancet"},{"key":"2644_CR3","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1111\/jch.13451","volume":"21","author":"GP Sogunuru","year":"2019","unstructured":"Sogunuru GP, Kario K, Shin J, Chen CH, Buranakitjaroen P, Chia YC, et al. Morning surge in blood pressure and blood pressure variability in Asia: Evidence and statement from the HOPE Asia Network. J Clin Hypertens. 2019;21:324\u201334.","journal-title":"J Clin Hypertens"},{"key":"2644_CR4","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1097\/HJH.0000000000001074","volume":"34","author":"S Omboni","year":"2016","unstructured":"Omboni S, Aristizabal D, De la Sierra A, Dolan E, Head G, Kahan T, et al. Hypertension types defined by clinic and ambulatory blood pressure in 14\u200a143 patients referred to hypertension clinics worldwide. Data from the ARTEMIS study. J Hypertens. 2016;34:2187\u201398.","journal-title":"J Hypertens"},{"key":"2644_CR5","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1038\/s41440-024-01744-1","volume":"47","author":"K Kario","year":"2024","unstructured":"Kario K, Hoshide S, Mogi M. Hypertension treatment update on World Hypertension Day 2024: current status and future prospects in Asia. Hypertens Res. 2024;47:1763\u20135.","journal-title":"Hypertens Res"},{"key":"2644_CR6","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1159\/000506396","volume":"54","author":"RV Krishnamurthi","year":"2020","unstructured":"Krishnamurthi RV, Ikeda T, Feigin VL. Global, Regional and Country-Specific Burden of Ischaemic Stroke, Intracerebral Haemorrhage and Subarachnoid Haemorrhage: A Systematic Analysis of the Global Burden of Disease Study 2017. Neuroepidemiology. 2020;54:171\u20139.","journal-title":"Neuroepidemiology"},{"key":"2644_CR7","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/s11255-023-03707-w","volume":"56","author":"Y Ren","year":"2024","unstructured":"Ren Y, Wang Z, Wang Q. The trend of hypertension-related chronic kidney disease from 1990 to 2019 and its predictions over 25 years: an analysis of the Global Burden of Disease Study 2019. Int Urol Nephrol. 2024;56:707\u201318.","journal-title":"Int Urol Nephrol"},{"key":"2644_CR8","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/s41569-022-00829-z","volume":"20","author":"JG Wang","year":"2023","unstructured":"Wang JG, Zhang W, Li Y, Liu L. Hypertension in China: epidemiology and treatment initiatives. Nat Rev Cardiol. 2023;20:531\u201345.","journal-title":"Nat Rev Cardiol"},{"key":"2644_CR9","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41569-025-01222-2","volume":"23","author":"D Zhao","year":"2026","unstructured":"Zhao D, Zhang Y, Wang J, He L, He Y, Ma C. Cardiovascular disease prevention in China: challenges and opportunities in the artificial intelligence-enabled digital health era. Nat Rev Cardiol. 2026;23:363\u201374.","journal-title":"Nat Rev Cardiol"},{"key":"2644_CR10","doi-asserted-by":"publisher","first-page":"3130","DOI":"10.1038\/s41440-025-02307-8","volume":"48","author":"K Kario","year":"2025","unstructured":"Kario K, Asayama K, Arima H, Matsumoto C, Nakagawa N, Nomura A, et al. Digital hypertension\u2014what we need for the high-quality management of hypertension in the new era. Hypertens Res. 2025;48:3130\u201346.","journal-title":"Hypertens Res"},{"key":"2644_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.26599\/1671-5411.2025.01.008","volume":"22","author":"JG Wang","year":"2025","unstructured":"Wang JG. Chinese guidelines for the prevention and treatment of hypertension (2024 revision). J Geriatr Cardiol. 2025;22:1\u2013149.","journal-title":"J Geriatr Cardiol"},{"key":"2644_CR12","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1038\/s41440-025-02331-8","volume":"48","author":"Y Ohya","year":"2025","unstructured":"Ohya Y, Sakima A, Arima H, Fukami A, Furuhashi M, Ishida M, et al. Key highlights of the Japanese Society of Hypertension Guidelines for the management of elevated blood pressure and hypertension 2025 (JSH2025). Hypertens Res. 2025;48:2500\u201311.","journal-title":"Hypertens Res"},{"key":"2644_CR13","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.35755\/jmedassocthai.2021.10.12199","volume":"104","author":"S Kunanon","year":"2021","unstructured":"Kunanon S, Chattranukulchai P, Chotruangnapa C, Kositanurit W, Methavigul K, Boonyasirinant T, et al. 2019 Thai guidelines on the treatment of hypertension: executive summary. J Med Assoc Thai. 2021;104:1729\u201338.","journal-title":"J Med Assoc Thai"},{"key":"2644_CR14","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1111\/jch.14580","volume":"24","author":"H Van Minh","year":"2022","unstructured":"Van Minh H, Van Huy T, Long DPP, Tien HA. Highlights of the 2022 Vietnamese Society of Hypertension guidelines for the diagnosis and treatment of arterial hypertension: The collaboration of the Vietnamese Society of Hypertension (VSH) task force with the contribution of the Vietnam National Heart Association (VNHA): The collaboration of the Vietnamese Society of Hypertension (VSH) task force with the contribution of the Vietnam National Heart Association (VNHA). J Clin Hypertens. 2022;24:1121\u201338.","journal-title":"J Clin Hypertens"},{"key":"2644_CR15","unstructured":"PERHI. Konsensus Penatalaksanaan Hipertensi 2019. Indonesian Society Hipertensi Indonesia. 2019;1\u201390."},{"key":"2644_CR16","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/s41371-020-0349-x","volume":"34","author":"SN Shah","year":"2020","unstructured":"Shah SN, Munjal YP, Kamath SA, Wander GS, Mehta N, Mukherjee S, et al. Indian guidelines on hypertension-IV (2019). J Hum Hypertens. 2020;34:745\u201358.","journal-title":"J Hum Hypertens"},{"key":"2644_CR17","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1016\/S0140-6736(23)00733-X","volume":"401","author":"N Staplin","year":"2023","unstructured":"Staplin N, de la Sierra A, Ruilope LM, Emberson JR, Vinyoles E, Gorostidi M, et al. Relationship between clinic and ambulatory blood pressure and mortality: an observational cohort study in 59\u2009124 patients. Lancet. 2023;401:2041\u201350.","journal-title":"Lancet"},{"key":"2644_CR18","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1001\/jama.2019.9811","volume":"322","author":"WY Yang","year":"2019","unstructured":"Yang WY, Melgarejo JD, Thijs L, Zhang ZY, Boggia J, Wei FF, et al. Association of office and ambulatory blood pressure with mortality and cardiovascular outcomes. JAMA. 2019;322:409\u201320.","journal-title":"JAMA"},{"key":"2644_CR19","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1111\/jch.14555","volume":"24","author":"K Kario","year":"2022","unstructured":"Kario K, Wang JG, Chia YC, Wang TD, Li Y, Siddique S, et al. The HOPE Asia network 2022 update consensus statement on morning hypertension management. J Clin Hypertens. 2022;24:1112\u201320.","journal-title":"J Clin Hypertens"},{"key":"2644_CR20","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1161\/HYPERTENSIONAHA.114.04262","volume":"64","author":"K Kario","year":"2014","unstructured":"Kario K, Saito I, Kushiro T, Teramukai S, Ishikawa Y, Mori Y, et al. Home blood pressure and cardiovascular outcomes in patients during antihypertensive therapy: primary results of HONEST, a large-scale prospective, real-world observational study. Hypertension. 2014;64:989\u201396.","journal-title":"Hypertension"},{"key":"2644_CR21","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1161\/HYPERTENSIONAHA.116.07201","volume":"68","author":"S Hoshide","year":"2016","unstructured":"Hoshide S, Yano Y, Haimoto H, Yamagiwa K, Uchiba K, Nagasaka S, et al. Morning and evening home blood pressure and risks of incident stroke and coronary artery disease in the Japanese general practice population: the Japan Morning Surge-Home Blood Pressure Study. Hypertension. 2016;68:54\u201361.","journal-title":"Hypertension"},{"key":"2644_CR22","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.numecd.2021.12.021","volume":"32","author":"X Liu","year":"2022","unstructured":"Liu X, Li F, Zheng Z, Li G, Zhou H, Zhang T, et al. Association of morning hypertension with chronic kidney disease progression and cardiovascular events in patients with chronic kidney disease and hypertension. Nutr Metab Cardiovasc Dis. 2022;32:965\u201372.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"2644_CR23","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1161\/HYPERTENSIONAHA.119.12955","volume":"74","author":"QH Guo","year":"2019","unstructured":"Guo QH, Cheng YB, Zhang DY, Wang Y, Huang QF, Sheng CS, et al. Comparison between home and ambulatory morning blood pressure and morning hypertension in their reproducibility and associations with vascular injury. Hypertension. 2019;74:137\u201344.","journal-title":"Hypertension"},{"key":"2644_CR24","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/jch.14440","volume":"24","author":"K Kario","year":"2022","unstructured":"Kario K, Chia YC, Siddique S, Turana Y, Li Y, Chen CH, et al. Seven-action approaches for the management of hypertension in Asia\u2014The HOPE Asia network. J Clin Hypertens. 2022r;24:213\u201323.","journal-title":"J Clin Hypertens"},{"key":"2644_CR25","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1161\/HYPERTENSIONAHA.124.24026","volume":"82","author":"J Liu","year":"2025","unstructured":"Liu J, Li Y, Asayama K, Zhang XJ, Cheng HM, Park S, et al. Asian expert consensus on nocturnal hypertension management. Hypertension. 2025;82:945\u201356.","journal-title":"Hypertension"},{"key":"2644_CR26","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1161\/HYPERTENSIONAHA.107.087767","volume":"50","author":"Y Li","year":"2007","unstructured":"Li Y, Staessen JA, Lu L, Li LH, Wang GL, Wang JG. Is isolated nocturnal hypertension a novel clinical entity? Findings from a Chinese population study. Hypertension. 2007;50:333\u20139.","journal-title":"Hypertension"},{"key":"2644_CR27","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.004198","volume":"5","author":"C Wang","year":"2016","unstructured":"Wang C, Li Y, Zhang J, Ye Z, Zhang Q, Ma X, et al. Prognostic effect of isolated nocturnal hypertension in chinese patients with nondialysis chronic kidney disease. J Am Heart Assoc. 2016;5:e004198.","journal-title":"J Am Heart Assoc"},{"key":"2644_CR28","doi-asserted-by":"publisher","first-page":"356","DOI":"10.2215\/CJN.14420920","volume":"16","author":"Q Wang","year":"2021","unstructured":"Wang Q, Wang Y, Wang J, Zhang L, Zhao MH, Chinese Cohort Study of Chronic Kidney Disease (C-STRIDE), et al. Nocturnal systolic hypertension and adverse prognosis in patients with CKD. Clin J Am Soc Nephrol. 2021;16:356\u201364.","journal-title":"Clin J Am Soc Nephrol"},{"key":"2644_CR29","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/jch.14757","volume":"26","author":"J Liu","year":"2024","unstructured":"Liu J, Li Y, Zhang X, Bu P, Du X, Fang L, et al. Management of nocturnal hypertension: An expert consensus document from the Chinese Hypertension League. J Clin Hypertens. 2024;26:71\u201383.","journal-title":"J Clin Hypertens"},{"key":"2644_CR30","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1093\/ajh\/hpad014","volume":"36","author":"T Maruhashi","year":"2023","unstructured":"Maruhashi T, Kinoshita Y, Ozono R, Nakamaru M, Ninomiya M, Oiwa J, et al. Significant correlates of nocturnal hypertension in patients with hypertension who are treated with antihypertensive drugs. Am J Hypertens. 2023;36:287\u201396.","journal-title":"Am J Hypertens"},{"key":"2644_CR31","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1161\/CIRCULATIONAHA.120.049730","volume":"142","author":"K Kario","year":"2020","unstructured":"Kario K, Hoshide S, Mizuno H, Kabutoya T, Nishizawa M, Yoshida T, et al. Nighttime blood pressure phenotype and cardiovascular prognosis: practitioner-based nationwide JAMP study. Circulation. 2020;142:1810\u201320.","journal-title":"Circulation"},{"key":"2644_CR32","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1038\/s41440-023-01336-5","volume":"46","author":"MX Li","year":"2023","unstructured":"Li MX, Zhang DY, Tang ST, Zheng QD, Huang QF, Sheng CS, et al. Control status of ambulatory blood pressure and its relationship with arterial stiffness in the China nationwide registry of treated hypertensive patients: the REACTION-ABP study. Hypertens Res. 2023;46:2302\u201311.","journal-title":"Hypertens Res"},{"key":"2644_CR33","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/S0140-6736(07)61538-4","volume":"370","author":"J Boggia","year":"2007","unstructured":"Boggia J, Li Y, Thijs L, Hansen TW, Kikuya M, Bj\u00f6rklund-Bodeg\u00e5rd K, et al. Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet. 2007;370:1219\u201329.","journal-title":"Lancet"},{"key":"2644_CR34","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1097\/HJH.0b013e32833b49fe","volume":"28","author":"HQ Fan","year":"2010","unstructured":"Fan HQ, Li Y, Thijs L, Hansen TW, Boggia J, Kikuya M, et al. Prognostic value of isolated nocturnal hypertension on ambulatory measurement in 8711 individuals from 10 populations. J Hypertens. 2010;28:2036\u201345.","journal-title":"J Hypertens"},{"key":"2644_CR35","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1097\/HJH.0000000000003363","volume":"41","author":"G Parati","year":"2023","unstructured":"Parati G, Bilo G, Kollias A, Pengo M, Ochoa JE, Castiglioni P, et al. Blood pressure variability: methodological aspects, clinical relevance and practical indications for management\u2014a European Society of Hypertension position paper \u2217. J Hypertens. 2023;41:527\u201344.","journal-title":"J Hypertens"},{"key":"2644_CR36","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1161\/HYPERTENSIONAHA.113.02681","volume":"63","author":"FF Wei","year":"2014","unstructured":"Wei FF, Li Y, Zhang L, Xu TY, Ding FH, Wang JG, et al. Beat-to-beat, reading-to-reading, and day-to-day blood pressure variability in relation to organ damage in untreated Chinese. Hypertension. 2014;63:790\u20136.","journal-title":"Hypertension"},{"key":"2644_CR37","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1097\/HJH.0000000000002444","volume":"38","author":"TL Zhou","year":"2020","unstructured":"Zhou TL, Rensma SP, van der Heide FCT, Henry RMA, Kroon AA, Houben AJHM, et al. Blood pressure variability and microvascular dysfunction: the Maastricht Study. J Hypertens. 2020;38:1541\u201350.","journal-title":"J Hypertens"},{"key":"2644_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.803810","volume":"9","author":"Y Liu","year":"2022","unstructured":"Liu Y, Luo X, Jia H, Yu B. The effect of blood pressure variability on coronary atherosclerosis plaques. Front Cardiovasc Med. 2022;9:803810.","journal-title":"Front Cardiovasc Med"},{"key":"2644_CR39","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1177\/0271678X221149937","volume":"43","author":"NL Starmans","year":"2023","unstructured":"Starmans NL, Wolters FJ, Leeuwis AE, Bron EE, Brunner La Rocca HP, Staals J, et al. Twenty-four-h blood pressure variability and the prevalence and progression of cerebral white matter hyperintensities. J Cereb Blood Flow Metab. 2023;43:801\u201311.","journal-title":"J Cereb Blood Flow Metab"},{"key":"2644_CR40","doi-asserted-by":"publisher","first-page":"i4098","DOI":"10.1136\/bmj.i4098","volume":"354","author":"SL Stevens","year":"2016","unstructured":"Stevens SL, Wood S, Koshiaris C, Law K, Glasziou P, Stevens RJ, et al. Blood pressure variability and cardiovascular disease: systematic review and meta-analysis. BMJ. 2016;354:i4098.","journal-title":"BMJ"},{"key":"2644_CR41","first-page":"204800401985649","volume":"8","author":"A de Havenon","year":"2019","unstructured":"de Havenon A, Stoddard G, Saini M, Wong KH, Tirschwell D, Bath P. VISTA-Acute Collaborators. Increased blood pressure variability after acute ischemic stroke increases the risk of death: a secondary analysis of the Virtual International Stroke Trial Archive. JRSM Cardiovasc Dis. 2019;8:2048004019856496.","journal-title":"JRSM Cardiovasc Dis"},{"key":"2644_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2023.1288109","volume":"10","author":"I Filchenko","year":"2023","unstructured":"Filchenko I, M\u00fcrner N, Dekkers MPJ, Baillieul S, Duss SB, Brill AK, et al. Blood pressure variability, nocturnal heart rate variability and endothelial function predict recurrent cerebro-cardiovascular events following ischemic stroke. Front Cardiovasc Med. 2023;10:1288109.","journal-title":"Front Cardiovasc Med"},{"key":"2644_CR43","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1161\/STROKEAHA.120.033751","volume":"53","author":"K Fukuda","year":"2022","unstructured":"Fukuda K, Matsuo R, Kamouchi M, Kiyuna F, Sato N, Nakamura K, et al. Day-by-day blood pressure variability in the subacute stage of ischemic stroke and long-term recurrence. Stroke. 2022;53:70\u201378.","journal-title":"Stroke"},{"key":"2644_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1139816","volume":"14","author":"L Wang","year":"2023","unstructured":"Wang L, Xia X, Liu X, Wu G, Wang Y, Yang D, et al. Twenty-four-h ambulatory blood pressure variability and association with ischemic stroke subtypes in the subacute stage. Front Neurol. 2023;14:1139816.","journal-title":"Front Neurol"},{"key":"2644_CR45","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1136\/svn-2020-000718","volume":"7","author":"T Wang","year":"2022","unstructured":"Wang T, Xu J, Wang A, Liu Y, Zhao X, Wang Y, et al. Night-time diastolic blood pressure variability relates to stroke recurrence in patients who had ischaemic stroke with small artery occlusion. Stroke Vasc Neurol. 2022;7:237\u201344.","journal-title":"Stroke Vasc Neurol"},{"key":"2644_CR46","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1038\/s41440-023-01500-x","volume":"47","author":"H Wang","year":"2024","unstructured":"Wang H, Guo Y, Xu J, Sun Y, Ji Y, Xu X, et al. Blood pressure variability and outcome in atherosclerosis versus cardioembolism cerebral large vessel occlusion after successful thrombectomy. Hypertens Res. 2024;47:898\u2013909.","journal-title":"Hypertens Res"},{"key":"2644_CR47","doi-asserted-by":"publisher","first-page":"346","DOI":"10.3389\/fneur.2019.00346","volume":"10","author":"JY Chang","year":"2019","unstructured":"Chang JY, Jeon SB, Jung C, Gwak DS, Han MK. Postreperfusion blood pressure variability after endovascular thrombectomy affects outcomes in acute ischemic stroke patients with poor collateral circulation. Front Neurol. 2019;10:346.","journal-title":"Front Neurol"},{"key":"2644_CR48","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1161\/STROKEAHA.117.016876","volume":"48","author":"L Kellert","year":"2017","unstructured":"Kellert L, Hametner C, Ahmed N, Rauch G, MacLeod MJ, Perini F, et al. Reciprocal interaction of 24-h blood pressure variability and systolic blood pressure on outcome in stroke thrombolysis. Stroke. 2017;48:1827\u201334.","journal-title":"Stroke"},{"key":"2644_CR49","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12882-024-03541-x","volume":"25","author":"Z Chen","year":"2024","unstructured":"Chen Z, Jiang X, Wu J, Lin L, Zhou Z, Li M, et al. Association between short-term blood pressure variability and target organ damage in non-dialysis patients with chronic kidney disease. BMC Nephrol. 2024;25:111.","journal-title":"BMC Nephrol"},{"key":"2644_CR50","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1097\/HJH.0000000000001670","volume":"36","author":"PA Sarafidis","year":"2018","unstructured":"Sarafidis PA, Ruilope LM, Loutradis C, Gorostidi M, de la Sierra A, de la Cruz JJ, et al. Blood pressure variability increases with advancing chronic kidney disease stage: a cross-sectional analysis of 16,546 hypertensive patients. J Hypertens. 2018;36:1076\u201385.","journal-title":"J Hypertens"},{"key":"2644_CR51","doi-asserted-by":"publisher","first-page":"e015359","DOI":"10.1161\/JAHA.120.015359","volume":"9","author":"Q Wang","year":"2020","unstructured":"Wang Q, Wang Y, Wang J, Zhang L, Zhao MH. C-STRIDE (Chinese Cohort Study of Chronic Kidney Disease)* \u2020. Short-term systolic blood pressure variability and kidney disease progression in patients with chronic kidney disease: results from C-STRIDE. J Am Heart Assoc. 2020;9:e015359.","journal-title":"J Am Heart Assoc"},{"key":"2644_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.911205","volume":"9","author":"G Wang","year":"2022","unstructured":"Wang G, Ma K, Ma Z, Guo X, Wang Y, Ma L, et al. Short-term blood pressure variability and outcomes in non-dialysis chronic kidney disease. Front Med. 2022;9:911205.","journal-title":"Front Med"},{"key":"2644_CR53","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s12882-023-03162-w","volume":"24","author":"Q Liu","year":"2023","unstructured":"Liu Q, Wang W, Wu X, Lv J, Cai S, Li Y. Intra-dialytic blood pressure variability is a greater predictor of cardiovascular events in hemodialysis patients. BMC Nephrol. 2023;24:113.","journal-title":"BMC Nephrol"},{"key":"2644_CR54","doi-asserted-by":"publisher","first-page":"c49","DOI":"10.1159\/000078400","volume":"97","author":"M Kojima","year":"2004","unstructured":"Kojima M, Taniguchi M, Sato K, Ueda R, Dohi Y. Antihypertensive effects of long-acting calcium channel blockers on hemodialysis days: a randomized crossover trial between benidipine and nifedipine CR. Nephron Clin Pr. 2004;97:c49\u201353.","journal-title":"Nephron Clin Pr"},{"key":"2644_CR55","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s00228-003-0620-4","volume":"59","author":"G Kungys","year":"2003","unstructured":"Kungys G, Naujoks H, Wanner C. Pharmacokinetics of amlodipine in hypertensive patients undergoing haemodialysis. Eur J Clin Pharmacol. 2003;59:291\u20135.","journal-title":"Eur J Clin Pharmacol"},{"key":"2644_CR56","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1053\/j.ajkd.2007.07.020","volume":"50","author":"R Minutolo","year":"2007","unstructured":"Minutolo R, Gabbai FB, Borrelli S, Scigliano R, Trucillo P, Baldanza D, et al. Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial. Am J Kidney Dis. 2007;50:908\u201317.","journal-title":"Am J Kidney Dis"},{"key":"2644_CR57","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1161\/HYPERTENSIONAHA.119.13512","volume":"74","author":"YB Cheng","year":"2019","unstructured":"Cheng YB, Thijs L, Zhang ZY, Kikuya M, Yang WY, Melgarejo JD, et al. Outcome-driven thresholds for ambulatory blood pressure based on the new American College of Cardiology\/American Heart Association Classification of Hypertension. Hypertension. 2019;74:776\u201383.","journal-title":"Hypertension"},{"key":"2644_CR58","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1097\/HJH.0000000000002074","volume":"37","author":"P Palatini","year":"2019","unstructured":"Palatini P, Saladini F, Mos L, Fania C, Mazzer A, Cozzio S, et al. Short-term blood pressure variability outweighs average 24-h blood pressure in the prediction of cardiovascular events in hypertension of the young. J Hypertens. 2019;37:1419\u201326.","journal-title":"J Hypertens"},{"key":"2644_CR59","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1097\/HJH.0000000000002618","volume":"39","author":"A de la Sierra","year":"2021","unstructured":"de la Sierra A, Mateu A, Gorostidi M, Vinyoles E, Segura J, Ruilope LM. Antihypertensive therapy and short-term blood pressure variability. J Hypertens. 2021;39:349\u201355.","journal-title":"J Hypertens"},{"key":"2644_CR60","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1161\/HYPERTENSIONAHA.111.174383","volume":"58","author":"Y Zhang","year":"2011","unstructured":"Zhang Y, Agnoletti D, Safar ME, Blacher J. Effect of antihypertensive agents on blood pressure variability: the Natrilix SR versus candesartan and amlodipine in the reduction of systolic blood pressure in hypertensive patients (X-CELLENT) study. Hypertension. 2011;58:155\u201360.","journal-title":"Hypertension"},{"key":"2644_CR61","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1097\/HJH.0000000000001608","volume":"36","author":"S Omboni","year":"2018","unstructured":"Omboni S, Kario K, Bakris G, Parati G. Effect of antihypertensive treatment on 24-h blood pressure variability: pooled individual data analysis of ambulatory blood pressure monitoring studies based on olmesartan mono or combination treatment. J Hypertens. 2018;36:720\u201333.","journal-title":"J Hypertens"},{"key":"2644_CR62","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/hr.2013.145","volume":"37","author":"G Parati","year":"2014","unstructured":"Parati G, Schumacher H. Blood pressure variability over 24 h: prognostic implications and treatment perspectives. An assessment using the smoothness index with telmisartan-amlodipine monotherapy and combination. Hypertens Res. 2014;37:187\u201393.","journal-title":"Hypertens Res"},{"key":"2644_CR63","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1093\/eurheartj\/ehv633","volume":"37","author":"G Mancia","year":"2016","unstructured":"Mancia G, Kjeldsen SE, Zappe DH, Holzhauer B, Hua TA, Zanchetti A, et al. Cardiovascular outcomes at different on-treatment blood pressures in the hypertensive patients of the VALUE trial. Eur Heart J. 2016;37:955\u201364.","journal-title":"Eur Heart J"},{"key":"2644_CR64","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.007131","volume":"6","author":"M Doumas","year":"2017","unstructured":"Doumas M, Tsioufis C, Fletcher R, Amdur R, Faselis C, Papademetriou V. Time in therapeutic range, as a determinant of all-cause mortality in patients with hypertension. J Am Heart Assoc. 2017;6:e007131.","journal-title":"J Am Heart Assoc"},{"key":"2644_CR65","doi-asserted-by":"publisher","first-page":"94","DOI":"10.2174\/0115734021346604250214071418","volume":"21","author":"W Riyadina","year":"2025","unstructured":"Riyadina W, Tuminah S, Indrawati L, Sitorus N, Letelay AM, Wurisastuti T, et al. The dose-response of blood pressure variability in stroke and coronary heart disease. Curr Hypertens Rev. 2025;21:94\u2013101.","journal-title":"Curr Hypertens Rev"},{"key":"2644_CR66","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1093\/eurheartj\/ehx760","volume":"39","author":"MH Mehlum","year":"2018","unstructured":"Mehlum MH, Liest\u00f8l K, Kjeldsen SE, Julius S, Hua TA, Rothwell PM, et al. Blood pressure variability and risk of cardiovascular events and death in patients with hypertension and different baseline risks. Eur Heart J. 2018;39:2243\u201351.","journal-title":"Eur Heart J"},{"key":"2644_CR67","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1161\/STROKEAHA.121.035851","volume":"53","author":"IJ McGurgan","year":"2022","unstructured":"McGurgan IJ, Kelly PJ, Turan TN, Rothwell PM. Long-term secondary prevention: management of blood pressure after a transient ischemic attack or stroke. Stroke. 2022;53:1085\u2013103.","journal-title":"Stroke"},{"key":"2644_CR68","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.009480","volume":"7","author":"BJ Kim","year":"2018","unstructured":"Kim BJ, Kwon SU, Wajsbrot D, Koo J, Park JM, Jeffers BW. Relationship of inter-individual blood pressure variability and the risk for recurrent stroke. J Am Heart Assoc. 2018;7:e009480.","journal-title":"J Am Heart Assoc"},{"key":"2644_CR69","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.1161\/STROKEAHA.119.026293","volume":"50","author":"A de Havenon","year":"2019","unstructured":"de Havenon A, Fino NF, Johnson B, Wong KH, Majersik JJ, Tirschwell D, et al. Blood pressure variability and cardiovascular outcomes in patients with prior stroke: a secondary analysis of PRoFESS. Stroke. 2019;50:3170\u20136.","journal-title":"Stroke"},{"key":"2644_CR70","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.022206","volume":"10","author":"A de Havenon","year":"2021","unstructured":"de Havenon A, Anadani M, Prabhakaran S, Wong KH, Yaghi S, Rost N. Increased blood pressure variability and the risk of probable dementia or mild cognitive impairment: a post hoc analysis of the SPRINT MIND trial. J Am Heart Assoc. 2021;10:e022206.","journal-title":"J Am Heart Assoc"},{"key":"2644_CR71","doi-asserted-by":"publisher","first-page":"2966","DOI":"10.1002\/alz.12935","volume":"19","author":"S Mahinrad","year":"2023","unstructured":"Mahinrad S, Bennett DA, Sorond FA, Gorelick PB. Blood pressure variability, dementia, and role of antihypertensive medications in older adults. Alzheimer's Dement. 2023;19:2966\u201374.","journal-title":"Alzheimer's Dement"},{"key":"2644_CR72","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1161\/HYPERTENSIONAHA.121.18658","volume":"79","author":"Y Wang","year":"2022","unstructured":"Wang Y, Zhao P, Chu C, Du MF, Zhang XY, Zou T, et al. Associations of long-term visit-to-visit blood pressure variability with subclinical kidney damage and albuminuria in adulthood: a 30-year prospective cohort study. Hypertension. 2022;79:1247\u201356.","journal-title":"Hypertension"},{"key":"2644_CR73","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.003825","volume":"5","author":"YC Chia","year":"2016","unstructured":"Chia YC, Lim HM, Ching SM. Long-term visit-to-visit blood pressure variability and renal function decline in patients with hypertension over 15 years. J Am Heart Assoc. 2016;5:e003825.","journal-title":"J Am Heart Assoc"},{"key":"2644_CR74","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/hr.2012.145","volume":"36","author":"K Yokota","year":"2013","unstructured":"Yokota K, Fukuda M, Matsui Y, Hoshide S, Shimada K, Kario K. Impact of visit-to-visit variability of blood pressure on deterioration of renal function in patients with non-diabetic chronic kidney disease. Hypertens Res. 2013;36:151\u20137.","journal-title":"Hypertens Res"},{"key":"2644_CR75","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1161\/HYPERTENSIONAHA.119.13422","volume":"74","author":"EH Bae","year":"2019","unstructured":"Bae EH, Lim SY, Han KD, Oh TR, Choi HS, Kim CS, et al. Association between systolic and diastolic blood pressure variability and the risk of end-stage renal disease. Hypertension. 2019;74:880\u20137.","journal-title":"Hypertension"},{"key":"2644_CR76","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.025513","volume":"11","author":"CH Park","year":"2022","unstructured":"Park CH, Kim HW, Joo YS, Park JT, Chang TI, Yoo TH, et al. Association between systolic blood pressure variability and major adverse cardiovascular events in korean patients with chronic kidney disease: findings from KNOW-CKD. J Am Heart Assoc. 2022;11:e025513.","journal-title":"J Am Heart Assoc"},{"key":"2644_CR77","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/ki.2013.132","volume":"84","author":"F Mallamaci","year":"2013","unstructured":"Mallamaci F, Minutolo R, Leonardis D, D\u2019Arrigo G, Tripepi G, Rapisarda F, et al. Long-term visit-to-visit office blood pressure variability increases the risk of adverse cardiovascular outcomes in patients with chronic kidney disease. Kidney Int. 2013;84:381\u20139.","journal-title":"Kidney Int"},{"key":"2644_CR78","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1093\/ckj\/sfac020","volume":"15","author":"S Park","year":"2022","unstructured":"Park S, Cho S, Lee S, Kim Y, Park S, Huh H, et al. Association between visit-to-visit blood pressure variability and risks of dementia in CKD patients: a nationwide observational cohort study. Clin Kidney J. 2022;15:1506\u201313.","journal-title":"Clin Kidney J"},{"key":"2644_CR79","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1161\/HYPERTENSIONAHA.111.190397","volume":"60","author":"P Rossignol","year":"2012","unstructured":"Rossignol P, Cridlig J, Lehert P, Kessler M, Zannad F. Visit-to-visit blood pressure variability is a strong predictor of cardiovascular events in hemodialysis: insights from FOSIDIAL. Hypertension. 2012;60:339\u201346.","journal-title":"Hypertension"},{"key":"2644_CR80","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1053\/j.ajkd.2008.04.032","volume":"52","author":"SM Brunelli","year":"2008","unstructured":"Brunelli SM, Thadhani RI, Lynch KE, Ankers ED, Joffe MM, Boston R, et al. Association between long-term blood pressure variability and mortality among incident hemodialysis patients. Am J Kidney Dis. 2008;52:716\u201326.","journal-title":"Am J Kidney Dis"},{"key":"2644_CR81","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1038\/s41440-019-0231-9","volume":"42","author":"Y Amari","year":"2019","unstructured":"Amari Y, Morimoto S, Iida T, Yurugi T, Oyama Y, Aoyama N, et al. Characteristics of visit-to-visit blood pressure variability in hemodialysis patients. Hypertens Res. 2019;42:1036\u201348.","journal-title":"Hypertens Res"},{"key":"2644_CR82","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1097\/HJH.0000000000003331","volume":"41","author":"N Kakaletsis","year":"2023","unstructured":"Kakaletsis N, Ntaios G, Milionis H, Protogerou AD, Karagiannaki A, Chouvarda I, et al. Time of blood pressure in the target range in acute ischemic stroke. J Hypertens. 2023;41:303\u20139.","journal-title":"J Hypertens"},{"key":"2644_CR83","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1161\/HYPERTENSIONAHA.122.20141","volume":"80","author":"LF Buckley","year":"2023","unstructured":"Buckley LF, Baker WL, Van Tassell BW, Cohen JB, Alkhezi O, Bress AP, et al. Systolic blood pressure time in the target range and major adverse kidney and cardiovascular events. Hypertension. 2023;80:305\u201313.","journal-title":"Hypertension"},{"key":"2644_CR84","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/s41440-024-01940-z","volume":"48","author":"K Kario","year":"2025","unstructured":"Kario K, Kanegae H, Hoshide S. Home blood pressure stability score is associated with better cardiovascular prognosis: data from the nationwide prospective J-HOP study. Hypertens Res. 2025;48:604\u201312.","journal-title":"Hypertens Res"},{"key":"2644_CR85","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.jacasi.2024.09.002","volume":"4","author":"X Han","year":"2024","unstructured":"Han X, Liu S, Zhou X, Chen S, Wu S, Yang Q. Systolic blood pressure time in target range and cardiovascular disease and premature death. JACC Asia. 2024;4:987\u201396.","journal-title":"JACC Asia"},{"key":"2644_CR86","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1161\/HYPERTENSIONAHA.124.24013","volume":"82","author":"H Wang","year":"2025","unstructured":"Wang H, Song J, Liu Z, Yu H, Wang K, Qin X, et al. Time in target range for blood pressure and adverse health outcomes: a systematic review. Hypertension. 2025;82:419\u201331.","journal-title":"Hypertension"},{"key":"2644_CR87","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1016\/j.jacc.2021.01.014","volume":"77","author":"N Fatani","year":"2021","unstructured":"Fatani N, Dixon DL, Van Tassell BW, Fanikos J, Buckley LF. Systolic blood pressure time in target range and cardiovascular outcomes in patients with hypertension. J Am Coll Cardiol. 2021;77:1290\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"2644_CR88","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/s41569-022-00690-0","volume":"19","author":"AE Schutte","year":"2022","unstructured":"Schutte AE, Kollias A, Stergiou GS. Blood pressure and its variability: classic and novel measurement techniques. Nat Rev Cardiol. 2022;19:643\u201354.","journal-title":"Nat Rev Cardiol"},{"key":"2644_CR89","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1093\/eurjpc\/zwad083","volume":"30","author":"Z Lin","year":"2023","unstructured":"Lin Z, Xiao Z, Chen W, Xu W, Huang C, Xie J, et al. Association of long-term time in target range for systolic blood pressure with cardiovascular risk in the elderly: a Chinese veteran cohort study. Eur J Prev Cardiol. 2023;30:969\u201377.","journal-title":"Eur J Prev Cardiol"},{"key":"2644_CR90","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41440-023-01416-6","volume":"47","author":"K Kario","year":"2024","unstructured":"Kario K, Tomitani N, Okawara Y, Kanegae H, Hoshide S. Home systolic blood pressure time in therapeutic range and cardiovascular risk: the practitioner-based nationwide J-HOP study extended. Hypertens Res. 2024;47:112\u20139.","journal-title":"Hypertens Res"},{"key":"2644_CR91","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.1093\/eurheartj\/ehaf220","volume":"46","author":"DY Zhang","year":"2025","unstructured":"Zhang DY, An DW, Yu YL, Melgarejo JD, Boggia J, Martens DS, et al. Ambulatory blood pressure monitoring, European guideline targets, and cardiovascular outcomes: an individual patient data meta-analysis. Eur Heart J. 2025;46:2974\u201387.","journal-title":"Eur Heart J"},{"key":"2644_CR92","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1093\/eurheartj\/ehad814","volume":"45","author":"A Gupta","year":"2024","unstructured":"Gupta A, Whiteley WN, Godec T, Rostamian S, Ariti C, Mackay J, et al. Legacy benefits of blood pressure treatment on cardiovascular events are primarily mediated by improved blood pressure variability: the ASCOT trial. Eur Heart J. 2024;45:1159\u201369.","journal-title":"Eur Heart J"},{"key":"2644_CR93","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1016\/j.jacc.2016.06.054","volume":"68","author":"EO Gosmanova","year":"2016","unstructured":"Gosmanova EO, Mikkelsen MK, Molnar MZ, Lu JL, Yessayan LT, Kalantar-Zadeh K, et al. Association of systolic blood pressure variability with mortality, coronary heart disease, stroke, and renal disease. J Am Coll Cardiol. 2016;68:1375\u201386.","journal-title":"J Am Coll Cardiol"},{"key":"2644_CR94","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/S1474-4422(10)70066-1","volume":"9","author":"PM Rothwell","year":"2010","unstructured":"Rothwell PM, Howard SC, Dolan E, O\u2019Brien E, Dobson JE, Dahlof B, et al. Effects of beta blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke. Lancet Neurol. 2010;9:469\u201380.","journal-title":"Lancet Neurol"},{"key":"2644_CR95","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/jch.12290","volume":"16","author":"P Muntner","year":"2014","unstructured":"Muntner P, Levitan EB, Lynch AI, Simpson LM, Whittle J, Davis BR, et al. Effect of chlorthalidone, amlodipine, and lisinopril on visit-to-visit variability of blood pressure: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. J Clin Hypertens. 2014;16:323\u201330.","journal-title":"J Clin Hypertens"},{"key":"2644_CR96","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1097\/HJH.0000000000003033","volume":"40","author":"A de Havenon","year":"2022","unstructured":"de Havenon A, Petersen N, Wolcott Z, Goldstein E, Delic A, Sheibani N, et al. Effect of dihydropyridine calcium channel blockers on blood pressure variability in the SPRINT trial: a treatment effects approach. J Hypertens. 2022;40:462\u20139.","journal-title":"J Hypertens"},{"key":"2644_CR97","doi-asserted-by":"publisher","DOI":"10.1080\/08037051.2025.2510317","volume":"34","author":"H Wang","year":"2025","unstructured":"Wang H, Zhang Y, Lin J, Shu Y, Bu P, Wang Z, et al. Impact of amlodipine-based therapy on blood pressure time in target range in Chinese adults with primary hypertension: a retrospective study. Blood Press. 2025;34:2510317.","journal-title":"Blood Press"},{"key":"2644_CR98","doi-asserted-by":"publisher","DOI":"10.1111\/jch.70151","volume":"27","author":"J Yang","year":"2025","unstructured":"Yang J, Chen S, Chai D, Peng F, Sun N, Lin J. Amlodipine-based therapy and its effect on time in target range and long-term blood pressure variability across age groups in chinese patients with primary hypertension: a retrospective study. J Clin Hypertens. 2025;27:e70151.","journal-title":"J Clin Hypertens"},{"key":"2644_CR99","first-page":"720","volume":"30","author":"China Hypertension League, Cardiovascular Metabolic Medicine Committee of Beijing Hypertension Prevention and Treatment Association","year":"2022","unstructured":"China Hypertension League, Cardiovascular Metabolic Medicine Committee of Beijing Hypertension Prevention and Treatment Association. Chinese expert consensus on smart wearables for blood pressure management in young and middle-aged adults. Chin J Hypertens. 2022;30:720\u20134.","journal-title":"Chin J Hypertens"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41440-026-02644-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-026-02644-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-026-02644-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:04:11Z","timestamp":1783296251000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-026-02644-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,12]]},"references-count":99,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["2644"],"URL":"https:\/\/doi.org\/10.1038\/s41440-026-02644-2","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,12]]},"assertion":[{"value":"17 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"BWT reports lecture fees, advisory board fees, or is a clinical trial investigator from Astra-Zeneca, Bayer, Baxter, Boehringer-Ingelheim, DKSH, Novartis, Otsuka, Radiant Pharmaceuticals, Roche, Takeda, and Vera Therapeutics. CYC has received speaker honorarium from Medtronic, Omron, Viatris and an educational grant from Medtronic on behalf of MyWASSH and from Viatris on behalf of the HOPE-Asia Network. HZ declares no conflicts of interest relevant to this work. JS reports honoraria from Skylabs, Menarini, Celltrion, and Novartis. J-GW reports having received lecture and consulting fees from AstraZeneca, Medtronic, Novartis, and Viatris. KK reports funded\/joint research fees and lecture fees from Omron Healthcare, A&D, and Fukuda Denshi. LY reports no known competing financial interests or personal relationships that could have appeared to influence the work reported in this consensus. YL reports having received research grants from A&D, Bayer, Omron, Salubris, and Shyndec and lecture fees from A&D, Servier, Salubris, and Viatris.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}